Etanercept for Psoriasis and Psoriatic Arthritis in a Patient with Charcot-Marie-Tooth Disease

Abstract

Get full access to this article

View all access options for this article.

References

Reilly

Shy

. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry. 2009;80:1304-1314.

Pareyson

Marchesi

. Natural history and treatment of peripheral inherited neuropathies. Adv Exp Med Biol. 2009;652:207-224.

Shy

Chen

Swan

. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology. 2008;70:378-383.

Pareyson

Marchesi

. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol. 2009;8:654-667.

Amerio

Amoruso

Bardazzi

. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis. J Dermatolog Treat. 2013;24:305-311.

Amici

Dunn

Jr Murphy

. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci. 2006;26:1179-1189.

Fortun

. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis. 2006;22:153-164.

Fortun

Verrier

. The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis. 2007;25:252-265.

Ginsberg

Malik

Kenton

. Coexistent hereditary and inflammatory neuropathy. Brain. 2004;127(pt 1):193-202.